Cargando…
Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
Introduction. Although 90% of prostate cancer is considered to be localized, 20%–30% of patients will experience biochemical failure (BF), defined as serum PSA >0.2 ng/mL, after radical prostatectomy (RP). The presence of circulating prostate cells (CPCs) in men without evidence of BF may be usef...
Autores principales: | Murray, Nigel P., Reyes, Eduardo, Orellana, Nelson, Fuentealba, Cynthia, Bádinez, Leonardo, Olivares, Ruben, Porcell, José, Dueñas, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628499/ https://www.ncbi.nlm.nih.gov/pubmed/23653529 http://dx.doi.org/10.1155/2013/762064 |
Ejemplares similares
-
Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications
por: Murray, Nigel P., et al.
Publicado: (2013) -
Combining the Prostate Cancer Risk Index (PRIX) with the Presence of Secondary Circulating Prostate Cells to Predict the Risk of Biochemical Failure after Radical Prostatectomy for Prostate Cancer
por: Murray, Nigel P, et al.
Publicado: (2018) -
Outcome of radical prostatectomy in primary circulating prostate cell negative prostate cancer
por: Murray, Nigel P, et al.
Publicado: (2016) -
Effect of Androgen Blockade on HER-2 and Matrix Metalloproteinase-2 Expression on Bone Marrow Micrometastasis and Stromal Cells in Men with Prostate Cancer
por: Murray, N. P., et al.
Publicado: (2013) -
10 Year Biochemical Failure Free Survival of Men with CD82 Positive Primary Circulating Prostate Cells Treated by Radical Prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2018)